In the latest quarter, 5 analysts provided ratings for OptimizeRx (NASDAQ:OPRX), showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Analysts have recently evaluated OptimizeRx and provided 12-month price targets. The average target is $14.4, accompanied by a high estimate of $16.00 and a low estimate of $11.00. A decline of 4.0% from the prior average price target is evident in the current average. Investigating Analyst Rati…